Mesco Pharmaceuticals has informed that Board of Directors had approved the appointment of Hawa Singh Chahar as an Additional Director (Non-Executive Independent Director) on the Board of the Company to hold office with immediate effect subject to the approval of shareholders of the company in the ensuing Annual General Meeting.
The above information is a part of company’s filings submitted to BSE.